Literature DB >> 11480450

Cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening.

S H Richards1, C Bankhead, T J Peters, J Austoker, F D Hobbs, J Brown, C Tydeman, L Roberts, J Formby, V Redman, S Wilson, D J Sharp.   

Abstract

OBJECTIVES: To examine the effectiveness and cost-effectiveness of two interventions based in primary care aimed at increasing uptake of breast screening.
SETTING: 24 General practices with low uptake in the second round of screening (below 60%) in north west London and the West Midlands, UK. Participants were all women registered with these practices and eligible for screening in the third round.
METHODS: Pragmatic factorial cluster randomised controlled trial, with practices randomised to a systematic intervention (general practitioner letter), an opportunistic intervention (flag in women's notes prompting discussion by health professionals), neither intervention, or both. Outcome measures were attendance for screening 6 months after the practices had been screened and cost-effectiveness of the interventions.
RESULTS: 6,133 Women were included: 1,721 control; 1,818 letter; 1,232 flag; 1,362 both interventions. Attendance data were obtained for 5,732 (93%) women. The two interventions independently increased breast screening uptake in a logistic regression model adjusted for clustering, with the flag (odds ratio (OR) 1.43, 95% confidence interval (95% CI) 1.14 to 1.79; p=0.0019) marginally more effective than the letter (OR 1.31, 95% CI 1.05 to 1.64; p=0.015). Health service costs per additional attendance were 26 pounds (letter) and 41 pounds (flag).
CONCLUSIONS: Although both interventions increased attendance for breast screening, the letter was the more cost-effective. Any decision to implement both interventions rather than just the letter will depend on whether the additional (41 pounds) costs are judged worthwhile in terms of the gains in breast screening uptake.

Entities:  

Mesh:

Year:  2001        PMID: 11480450     DOI: 10.1136/jms.8.2.91

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  9 in total

Review 1.  Organizational factors and the cancer screening process.

Authors:  Rebecca Anhang Price; Jane Zapka; Heather Edwards; Stephen H Taplin
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studies.

Authors:  Erinn M Hade; David M Murray; Michael L Pennell; Dale Rhoda; Electra D Paskett; Victoria L Champion; Benjamin F Crabtree; Allen Dietrich; Mark B Dignan; Melissa Farmer; Joshua J Fenton; Susan Flocke; Robert A Hiatt; Shawna V Hudson; Michael Mitchell; Patrick Monahan; Salma Shariff-Marco; Stacey L Slone; Kurt Stange; Susan L Stewart; Pamela A Ohman Strickland
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.

Authors:  Sarah Knerr; Karen J Wernli; Kathleen Leppig; Kelly Ehrlich; Amanda L Graham; David Farrell; Chalanda Evans; George Luta; Marc D Schwartz; Suzanne C O'Neill
Journal:  Contemp Clin Trials       Date:  2017-02-28       Impact factor: 2.226

4.  Cluster randomized trials of cancer screening interventions: are appropriate statistical methods being used?

Authors:  Catherine M Crespi; Annette E Maxwell; Sheng Wu
Journal:  Contemp Clin Trials       Date:  2011-03-05       Impact factor: 2.226

5.  A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada.

Authors:  Claire E Kendall; Sharon Walmsley; Cindy Lau; Nathaniel Jembere; Ann N Burchell; Mona Loutfy; Janet Raboud; Ron Rosenes; Sean B Rourke; Tony Antoniou
Journal:  CMAJ Open       Date:  2017-08-30

6.  Manually-generated reminders delivered on paper: effects on professional practice and patient outcomes.

Authors:  Tomas Pantoja; Jeremy M Grimshaw; Nathalie Colomer; Carla Castañon; Javiera Leniz Martelli
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

7.  Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial.

Authors:  Fiona Riordan; Emmy Racine; Susan M Smith; Aileen Murphy; John Browne; Patricia M Kearney; Colin Bradley; Mark James; Mark Murphy; Sheena M McHugh
Journal:  Pilot Feasibility Stud       Date:  2020-05-12

8.  Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis.

Authors:  Rebecca Mottram; Wendy Lynn Knerr; Daniel Gallacher; Hannah Fraser; Lena Al-Khudairy; Abimbola Ayorinde; Sian Williamson; Chidozie Nduka; Olalekan A Uthman; Samantha Johnson; Alexander Tsertsvadze; Christopher Stinton; Sian Taylor-Phillips; Aileen Clarke
Journal:  BMJ Open       Date:  2021-11-30       Impact factor: 2.692

9.  Effect size and cost-effectiveness estimates of breast and cervical cancer screening reminders by population size through complete enumeration of Japanese local municipalities.

Authors:  Shigekazu Komoto; Yuji Nishiwaki; Tomonori Okamura; Hideo Tanaka; Toru Takebayashi
Journal:  BMC Public Health       Date:  2014-01-16       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.